Severe Cerebral Vasospasm in Patients with Hyperthyroidism

다국어 초록 (Multilingual Abstract)

Cerebral vasospasm associated with hyperthyroidism has not been reported to cause cerebral infarction. The case reported here is therefore the first of cerebral infarction co-existing with severe vasospasm and hyperthyroidism. A 30-year-old woman was transferred to our hospital in a stuporous state with right hemiparesis. At first, she complained of headache and dizziness. However, she had no neurological deficits or radiological abnormalities. She was diagnosed with hyperthyroidism 2 months ago, but she had discontinued the antithyroid medication herself three days ago. Magnetic resonance imaging and angiography showed cerebral infarction with severe vasospasm. Thus, chemical angioplasty using verapamil was performed two times, and antithyroid medication was administered. Follow-up angiography performed at 6 weeks demonstrated complete recovery of the vasospasm. At the 2-year clinical follow-up, she was alert with mild weakness and cortical blindness. Hyperthyroidism may influence cerebral vascular hemodynamics. Therefore, a sudden increase in the thyroid hormone levels in the clinical setting should be avoided to prevent cerebrovascular accidents. When neurological deterioration is noticed without primary cerebral parenchyma lesions, evaluation of thyroid function may be required before the symptoms occur.

참고문헌 (Reference)

1 Ichiki T., "Thyroid hormone and vascular remodeling" 23 (23): 266-275, 2016

2 Owen PJ, "Thyroid disease and vascular function" 17 (17): 519-524, 2007

3 이시원, "The Impact of Subclinical Hypothyroidism or Thyroid Autoimmunity on Coronary Vasospasm in Patients without Associated Cardiovascular Risk Factors" 대한심장학회 45 (45): 125-130, 2015

4 Masani ND, "Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction" 74 (74): 700-701, 1995

5 Choi YH, "Severe coronary artery spasm can be associated with hyperthyroidism" 16 (16): 135-139, 2005

6 Inagawa T, "Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature" 85 : 56-76, 2016

7 Martin NA, "Posttraumatic cerebral arterial spasm: transcranial Doppler ultrasound, cerebral blood flow, and angiographic findings" 77 (77): 575-583, 1992

8 Zeiler FA, "Norepinephrine as a potential aggravator of symptomatic cerebral vasospasm: two cases and argument for milrinone therapy" 2014 : 630970-, 2014

9 Ni J, "Moyamoya syndrome associated with Graves' disease: a case series study" 2 (2): 77-, 2014

10 Hayashi K, "JR-NET2 study group. Current status of endovascular treatment for vasospasm following subarachnoid hemorrhage: analysis of JR-NET2" 54 (54): 107-112, 2014

11 Lincoln J., "Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline" 68 (68): 473-501, 1995

12 Napoli R, "Impact of hyperthyroidism and its correction on vascular reactivity in humans" 104 (104): 3076-3080, 2001

13 Patel R, "Hyperthyroidism-associated coronary vasospasm with myocardial infarction and subsequent euthyroid angina" 18 (18): 273-276, 2008

14 Chudleigh RA, "Graves' thyrotoxicosis and coronary artery spasm" 83 (83): e5-, 2007

15 Pandey AS, "Endovascular treatment of cerebral vasospasm: vasodilators and angioplasty" 23 (23): 593-604, 2013

16 Chalouhi N, "Endovascular management of cerebral vasospasm following aneurysm rupture: outcomes and predictors in 116 patients" 118 : 26-31, 2014

17 Ohba S, "Concurrent Graves'disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment" 34 (34): 297-304, 2011

18 Chen JB, "Clinical features and disease progression in moyamoya disease patients with Graves disease" 123 (123): 848-855, 2015

19 Kramer DR, "Cerebral vasospasm in traumatic brain injury" 2013 : 415813-, 2013

20 Lassnig E, "Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism" 90 (90): 333-335, 2003

21 Kim SJ, "Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study" 41 (41): 173-176, 2010

22 Lei C, "Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis" 21 (21): 996-1001, 2014

23 Duckworth JW, "Aminergic histofluorescence and contractile responses to transmural electrical field stimulation and norepinephrine of human middle cerebral arteries obtained promptly after death" 65 (65): 316-324, 1989